(Q67274000)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference

R Johansson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

P Kilkku

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

M Groenroos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

publication date

1 December 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

9 Suppl B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

25-33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980032-7

7 January 2021

Clinical pharmacology of nabilone, a cannabinol derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980032-7

7 January 2021

Suppression of the cardiac conditioned response by delta-9-tetrahydrocannabinol: a comparison with other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980032-7

7 January 2021

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980032-7

7 January 2021

10.1016/S0305-7372(82)80032-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6299551%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference